US Edition
Medtronic TAVI platforms gain CE mark for expanded redo TAVI indication - Cardiovascular News
Summary by Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Medtronic TAVI platforms gain CE mark for expanded redo TAVI indication - Cardiovascular News
Evolut PRO+ Medtronic has announced it has received CE mark for the expanded redo transcatheter aortic valve implantation (TAVI) indication of the Evolut PRO+ and FX TAVI systems. This approval allows for the implantation of a new Evolut transcatheter aortic valve (TAV) inside any failed previously implanted TAV. The redo TAVI procedure is indicated for the failure of any TAV, regardless of the manufacturer, amongst patients with severe aortic s…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
